115 related articles for article (PubMed ID: 33342532)
1. Corrigendum to 'ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2' [Canc. Lett. 427 (2018) 9-17].
Luo Q; Wu X; Zhang Y; Shu T; Ding F; Chen H; Zhao P; Chang W; Zhu X; Liu Z
Cancer Lett; 2021 Feb; 498():243. PubMed ID: 33342532
[No Abstract] [Full Text] [Related]
2. ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2.
Luo Q; Wu X; Zhang Y; Shu T; Ding F; Chen H; Zhao P; Chang W; Zhu X; Liu Z
Cancer Lett; 2018 Jul; 427():9-17. PubMed ID: 29660381
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134].
Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
Cancer Lett; 2022 Jul; 539():215695. PubMed ID: 35501203
[No Abstract] [Full Text] [Related]
4. Corrigendum to "DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer" [Canc. Lett. 501 224-233].
Moskovich D; Alfandari A; Finkelshtein Y; Weisz A; Katzav A; Kidron D; Edelstein E; Veroslavski D; Perets R; Arbib N; Kadan Y; Fishman A; Lerer B; Ellis M; Ashur-Fabian O
Cancer Lett; 2023 Jun; 563():216196. PubMed ID: 37104919
[No Abstract] [Full Text] [Related]
5. Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56].
Leung HW; Lau EYT; Leung CON; Lei MML; Mok EHK; Ma VWS; Cho WCS; Ng IOL; Yun JP; Cai SH; Yu HJ; Ma S; Lee TKW
Cancer Lett; 2021 Feb; 499():2. PubMed ID: 32563702
[No Abstract] [Full Text] [Related]
6. Corrigendum to "UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation" [Canc. Lett. 494 (2020) 121-131].
Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
Cancer Lett; 2022 Sep; 543():215792. PubMed ID: 35718664
[No Abstract] [Full Text] [Related]
7. Corrigendum to "FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer" [Canc. Lett. 397 (2017) 83-93].
Hu X; Zhai Y; Kong P; Cui H; Yan T; Yang J; Qian Y; Ma Y; Wang F; Li H; Cheng C; Zhang L; Jia Z; Li Y; Yang B; Xu E; Wang J; Yang J; Bi Y; Chang L; Wang Y; Zhang Y; Song B; Li G; Shi R; Liu J; Zhang M; Cheng X; Cui Y
Cancer Lett; 2020 Dec; 494():1-2. PubMed ID: 32818769
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM." [Canc. Lett. 449 (2019) 31-44].
Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
Cancer Lett; 2021 Mar; 500():292-293. PubMed ID: 33390287
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands" [Canc. Lett. 403 (2017) 98-107].
Allison SJ; Sadiq M; Baronou E; Cooper PA; Dunnill C; Georgopoulos NT; Latif A; Shepherd S; Shnyder SD; Stratford IJ; Wheelhouse RT; Willans CE; Phillips RM
Cancer Lett; 2018 Sep; 431():247. PubMed ID: 29934232
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy" [Canc. Lett 244 (2006) 182-189].
Ji Z; Yang G; Shahzidi S; Tkacz-Stachowska K; Suo Z; Nesland JM; Peng Q
Cancer Lett; 2021 Feb; 498():244. PubMed ID: 33109413
[No Abstract] [Full Text] [Related]
11. Corrigendum to "MLKL contributes to shikonin-induced glioma cell necroptosis via promotion of chromatinolysis" [Canc. Lett. 467 (2019) 58-71].
Ding Y; He C; Lu S; Wang X; Wang C; Wang L; Zhang J; Piao M; Chi G; Luo Y; Sai K; Ge P
Cancer Lett; 2020 Mar; 472():183. PubMed ID: 31917020
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer" [Canc. Lett. 459(2019)204-215].
Zhang B; Ye H; Ren X; Zheng S; Zhou Q; Chen C; Lin Q; Li G; Wei L; Fu Z; Zhang Y; Hu C; Li Z; Chen R
Cancer Lett; 2022 Nov; 548():215897. PubMed ID: 36050250
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Targeting autophagy in cancer stem cells as an anticancer therapy" [Canc. Lett. 393 (2017) 33-39].
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2018 Mar; 416():149. PubMed ID: 29307478
[No Abstract] [Full Text] [Related]
14. Corrigendum to " 2'-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling" [Canc. Lett. 471 (2020) 135-146].
Yue Y; Qian W; Li J; Wu S; Zhang M; Wu Z; Ma Q; Wang Z
Cancer Lett; 2022 Nov; 549():215913. PubMed ID: 36152564
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer" [Canc. Lett. 438 (2018, Dec 1) 165-173].
Lin CC; Lo MC; Moody R; Jiang H; Harouaka R; Stevers N; Tinsley S; Gasparyan M; Wicha M; Sun D
Cancer Lett; 2020 Jun; 480():51. PubMed ID: 32229161
[No Abstract] [Full Text] [Related]
16. Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
Cancer Lett; 2018 Sep; 431():244. PubMed ID: 29754994
[No Abstract] [Full Text] [Related]
17. Corrigendum to "TGF-β1 targets a microRNA network that regulates cellular adhesion and migration in renal cancer" [Canc. Lett. 412 (2018) 155-169].
Bogusławska J; Rodzik K; Popławski P; Kędzierska H; Rybicka B; Sokół E; Tański Z; Piekiełko-Witkowska A
Cancer Lett; 2020 Jun; 480():52-55. PubMed ID: 32005526
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasis" [Canc. Lett. 461 (2019) 65-77].
Tonucci FM; Almada E; Borini-Etichetti C; Pariani A; Hidalgo F; Rico MJ; Girardini J; Favre C; Goldenring JR; Menacho-Marquez M; Larocca MC
Cancer Lett; 2020 Mar; 473():200-201. PubMed ID: 31932121
[No Abstract] [Full Text] [Related]
19. Corrigendum to "MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer", [Canc. Lett. 399 (2017) 53-63].
Ou C; Sun Z; Li X; Li X; Ren W; Qin Z; Zhang X; Yuan W; Wang J; Yu W; Zhang S; Peng Q; Yan Q; Xiong W; Li G; Ma J
Cancer Lett; 2018 Apr; 420():260. PubMed ID: 29429755
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
Casal-Mouriño A; Ruano-Ravina A; Torres-Durán M; Parente-Lamelas I; Provencio-Pulla M; Castro-Añón O; Vidal-García I; Pena-Álvarez C; Abal-Arca J; Piñeiro-Lamas M; Fuente-Merino I; Fernández-Villar A; Abdulkader I; Valdés-Cuadrado L; Barros-Dios JM; Pérez-Ríos M
Cancer Lett; 2020 Nov; 493():10. PubMed ID: 32810636
[No Abstract] [Full Text] [Related]
[Next] [New Search]
